Prospective Cohort Study of Polycystic Kidney Disease in Thai Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20210324006

Enrollment

200

Registered

2021-03-24

Start date

2021-05-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic kidney diseases Polycystic kidney diseases ADPKD Chronic kidney disease Genetic study Total kidney volume

Interventions

None listed

Eligibility

Sex/Gender

All

Age

15 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosed of genetic polycystic kidney diseases (PKD) from either clinical criteria or genetic study

Exclusion criteria

Exclusion criteria: Existing non-genetic cause of PKD eGFR of less than 6 ml/min/m2 Kidney transplant recipient Received renal replacement therapy except for indication of acute kidney injury Pregnancy Terminally ill eg. advance-staged heart failure with NYHA class IV, advance-staged lung disease, cirrhosis CTP score B or C, PLUS Karnofsky Performance Score of 40 or less

Design outcomes

Primary

Measure	Time frame
Rate of eGFR reduction 60 months after enrollement CKD-EPI equation	—

Secondary

Measure	Time frame
Incidence of eGFR reduction of 40% or more At 60 months after enrollment CKD-EPI equation,All-cause mortality At 60 months after enrollment Frequency,End-stage renal disease At 60 months after enrollment Frequency,Major adverse cardiovascular events At 60 months after enrollment Frequency,Polycystic kidney disease-related complications At 60 months after enrollment Frequency,Interventions associated with polycystic kidney diseases At 60 months after enrollment Frequency	—

Measure

Time frame

Incidence of eGFR reduction of 40% or more At 60 months after enrollment CKD-EPI equation,All-cause mortality At 60 months after enrollment Frequency,End-stage renal disease At 60 months after enrollment Frequency,Major adverse cardiovascular events At 60 months after enrollment Frequency,Polycystic kidney disease-related complications At 60 months after enrollment Frequency,Interventions associated with polycystic kidney diseases At 60 months after enrollment Frequency

—

Countries

Thailand

Contacts

Public ContactSomkanya Tungsanga

Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University

s.tungsanga@gmail.com0816291939

Outcome results